Literature DB >> 25013372

Renal transplantation: relationship between hospital/surgeon volume and postoperative severe sepsis/graft-failure. a nationwide population-based study.

Shih-Feng Weng1, Chin-Chen Chu2, Chih-Chiang Chien3, Jhi-Joung Wang4, Yi-Chen Chen4, Shang-Jyh Chiou5.   

Abstract

UNLABELLED: BACKGROUND AND OBJECTS: We explored the relationship between hospital/surgeon volume and postoperative severe sepsis/graft-failure (including death).
METHODS: The Taiwan National Health Insurance Research Database claims data for all patients with end-stage renal disease patients who underwent kidney transplantation between January 1, 1999, and December 31, 2007, were reviewed. Surgeons and hospitals were categorized into two groups based on their patient volume. The two primary outcomes were severe sepsis and graft failure (including death). The logistical regressions were done to compute the Odds ratios (OR) of outcomes after adjusting for possible confounding factors. Kaplan-Meier analysis was used to calculate the cumulative survival rates of graft failure after kidney transplantation during follow-up (1999-2008).
RESULTS: The risk of developing severe sepsis in a hospital in which surgeons do little renal transplantation was significant (odds ratio [OR]; p = 0.0115): 1.65 times (95% CI: 1.12-2.42) higher than for a hospital in which surgeons do many. The same trend was true for hospitals with a low volume of renal transplantations (OR = 2.39; 95% CI: 1.62-3.52; p < 0.0001). The likelihood of a graft failure (including death) within one year for the low-volume surgeon group was 3.1 times higher than for the high-volume surgeon group (p < 0.0001); the trend was similar for hospital volume. Female patients had a lower risk than did male patients, and patients ≥ 55 years old and those with a higher Charlson comorbidity index score, had a higher risk of severe sepsis.
CONCLUSIONS: We conclude that the risk of severe sepsis and graft failure (including death) is higher for patients treated in hospitals and by surgeons with a low volume of renal transplantations. Therefore, the health authorities should consider exporting best practices through educational outreach and regulation and then providing transparent information for public best interest.

Entities:  

Keywords:  graft failure; population-based; renal transplantation; sepsis; volume-outcome relationship.

Mesh:

Year:  2014        PMID: 25013372      PMCID: PMC4081314          DOI: 10.7150/ijms.8850

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


Introduction

Studies on surgeons and hospitals with higher caseloads provide evidence of better outcomes in major surgery, especially in cancer 1-3; however, the association is controversial in different healthcare systems 4 and some types of surgery. Despite the benefits of volume, the controversy claimed it is due to the concentration of hospital care supply and also concerned medical skills loss in lower level hospital and patients will flow to higher level hospital. Graft rejection and infection were the two major causes of death in renal transplant recipients from the 1970s until the mid-1980s 5. Because of improved immunosuppressive protocols and surgical techniques, the incidence of graft rejection has impressively decreased 6. Despite recent advances in management and therapy, postoperative infection remains high, around 40% 7-9, and exceeds acute rejection as the leading cause of hospitalization in renal transplant recipients with a functioning allograft 10. Sepsis is a systemic and deleterious host response to infection, and severe sepsis is defined as sepsis with acute organ dysfunction, hypoperfusion (including oliguria, lactic acidosis, or encephalopathy), or hypotension 11, 12. The incidence of severe sepsis after most elective operative procedures increased from 0.3% in 1997 to 0.9% in 2006 13. In the U.S., organ transplant recipients are at an especially high risk for developing severe sepsis 14. It is the most common life-threatening complication of long-term immunosuppressive therapy and is the main reason for intensive care unit (ICU) admission of renal transplant recipients 8. An ICU admission is associated with a decreased graft longevity rate and a higher post-transplantation mortality rate 8, 15. Moreover, patients with severe sepsis might develop multiple septic episodes during the same hospitalization or after discharge 16, 17. Multiple factors are associated with the development of severe sepsis after kidney transplantation, e.g., the intensity of exposure to potential pathogens (epidemiologic exposure) and the combined effect of all of the factors that contribute to a patient's susceptibility to infection 18. Moreover, many factors contribute to the development of severe sepsis 18. Preventing and managing severe sepsis places extraordinary demands, not only on surgeons, but also on other medical personnel, including anesthesiologists, diagnostic and interventional radiologists, critical care specialists, nursing, and nutritional support service workers. The level of the surgeons' transplantation experience and the level of the hospital transplantation teams' quality of care may significantly contribute to reducing the incidence of severe sepsis post-transplantation. Multiple studies 7, 19, 20 have shown an association between hospital volume and surgical outcomes for organ transplantations. However, the effect of surgeon or hospital volume on severe sepsis is not yet clear despite its being a key factor associated with both graft longevity and patient survival. This study aims to explore the relationship between the surgeon or hospital volume with consideration of the postoperative severe sepsis or graft-failure (including death). Therefore, we investigated this question on a nationwide scale using claims data from the Taiwan National Health Insurance Database.

Study population and Methods

Database

The data for this study were obtained from Taiwan National Health Insurance Research Database (NHIRD) of the Taiwan National Health Research Institute. The NHIRD, which covers nearly all inpatient and outpatient medical benefit claims for the Taiwanese population of over 22 million (about 99% of Taiwan's population in 2008), is one of the most comprehensive nationwide population-based data sources currently available and has been used extensively in many epidemiological studies. The NHIRD provides encrypted patient identification numbers, gender, date of birth, dates of admission and discharge, the ICD-9-CM (International Classification of Diseases, Ninth Revision, Clinical Modification) codes of diagnoses (up to five) and procedures (up to five), details of prescriptions, and expenditure amounts. It also includes a registry of contracted medical facilities, and a registry of board-certified surgeons. With ethical approval from National Health Research Institute, we used data for the ambulatory care claims, all inpatient claims, and registry for patients with catastrophic illnesses for this study. All NHI datasets can be interlinked with each individual personal identification number.

Selection of patients and variables

All patients with end-stage renal disease (ESRD) who underwent kidney transplantation between January 1, 1999, and December 31, 2007, were identified by the ICD-9 CM procedure code 55.69. Patients with unknown gender or missing data were excluded. All patients were followed-up through December 31, 2008. Seventeen hundred seventy-nine kidney transplantations were done by 142 surgeons in 35 hospitals during this period. Physicians and hospitals were categorized by their total patient volume by using their unique identifiers in the database. The sample of 1779 patients was divided into two groups: the low-volume group (first 1/3) and the medium- and high-volume group (second 1/3 [medium-volume] and third 1/3 [high-volume]), based on physician volume: ≤ 33 transplantations (low-volume), and > 33 transplantations (medium- and high-volume), and the hospital sample was divided into two groups: ≤ 95 transplantations (low-volume), and > 95 transplantations (medium- and high-volume). The two primary outcomes were severe sepsis and graft failure (including death). The ICD-9-CM codes for the sepsis in this study used the definition from Angus et al 21, severe sepsis was defined as sepsis complicated by organ dysfunction. The key independent variables were the kidney transplantation volumes both for physicians and for hospitals. Other physician attributes included age (≤ 40, 40-49, and ≥ 50) and gender. The hospitals were grouped by public or private ownership. Patient characteristics included age (≤ 20, 21-55, and > 55), gender, and modified Charlson Comorbidity Index score 22, which was used to infer the health status of each patient; higher sums of weighted scores indicated higher disease severity.

Statistical Analysis

Descriptive statistical analyses using Pearson χ2 tests were done to compare the characteristics of patients, physicians, and hospitals with physician volume and hospital volume. The association between medical costs and physician volume, medical costs and hospital volume, length of stay in hospital and physician volume, and length of stay in hospital and hospital volume were determined using Students' t-test. Unconditional logistic regression analyses were used assess the crude odds ratio of (1) severe sepsis and (2) graft failure (including death) at one year between the physician volume and hospital volume groups. Moreover, multivariate logistic regression using the generalized estimated equation method (GEE), which clusters hospital volume, was used to obtain the adjusted odds ratio (AOR) of graft failure (including death) at one year between the physician volume groups. GEE method accounts for the fact that patients within the same hospital volume group may be more similar to each other than they are to patients in other hospital volume groups because of specific physician and treatment practices. Kaplan-Meier analysis was used to calculate the cumulative survival rates of graft failure (including death) after kidney transplantation in a 10-year (1999-2008) follow-up period, and the log-rank test was used to test the differences between the survival curves. Survival time was measured from the date of kidney transplantation until the day of graft failure or death or until the end of the study. SAS 9.3.1 (SAS Institute, Cary, NC) was used for all statistical analyses. The alpha value indicated significance at the 0.05 level.

Results

The mean medical cost and length of stay (hospitalization) was significantly less in the high physician-volume groups than in the low physician-volume groups (new Taiwan dollars (NT$) 195,223 vs. NT$257,495; 17.56 vs. 19.84 days, respectively; P < 0.0001). There was no significant difference in the gender of the patients, but significantly (P < 0.0001) more than 80% of the patients were in the 21-55 years old age group in both the high- and low-volume groups. Interestingly, in the low-volume group, a higher proportion of patients had more comorbidities (CCI > 2). In addition, physician attributes (gender and age), were both significantly different (P < 0.0001) between the high- and low-volume physicians (Table 1).
Table 1

The distributions of basic characteristics by physician volume with medical cost and length of stay.

Physician Volume
Low (1-33)High (> 33)P-value
Total number of physicians12814
Total number of patients619 (34.79)1160 (65.21)
Mean medical cost (NT$)257,495 ± 204,344195,223 ± 126,356< 0.0001
Mean length of stay (days)19.84 ± 19.6417.56 ± 10.040.0013
Patient attributes
Gender
Male308 (49.76)557 (48.02)
Female311 (50.24)603 (51.98)0.4842
Age (years)
≤ 2046 (7.43)57 (4.91)0.0411
21-55519 (83.84)976 (84.14)
> 5554 (8.72)127 (10.95)
CCI score
0380 (61.39)819 (70.61)0.0002
1157 (25.36)239 (20.60)
> 282 (13.25)102 (8.79)
Physician attributes
Gender
Male593 (95.80)1160 (100.00)< 0.0001
Female26 (4.20)0
Age (years)
≤ 40206 (33.28)326 (28.10)0.0003
40-49281 (45.40)486 (41.90)
≥ 50132 (21.32)348 (30.00)

NT$, new Taiwan dollars; CCI, Charlson Comorbidity Index.

The distributions of patient attributes were similar when stratifying by hospital volume. Mean medical cost was significantly lower in the high-volume hospital groups than in the low-volume hospital groups (NT$205,784 vs. NT$238,175, respectively; P < 0.0001), but mean length of stay was not significantly different (Table 2).
Table 2

The distributions of basic characteristics by hospital volume with medical cost and length of stay.

Hospital Volume
Low (≤ 95)High (> 95)P-value
Total number of hospitals305
Total number of patients610 (34.29)1169 (65.71)
Mean medical cost (NT$)238,175 ± 162,801205,784 ± 158,420< 0.0001
Mean length of stay(days)18.58 ± 13.8018.23 ± 14.350.626
Patient attributes
Gender
Male307 (50.33)611 (52.27)
Female303 (49.67)558 (47.73)0.2986
Age (years)
≤ 2026 (4.26)77 (6.59)0.0561
21-55529 (86.72)966 (82.63)
> 5555 (9.02)126 (10.78)
CCI score
0394 (64.59)805 (68.86)0.1816
1149 (24.43)247 (21.13)
> 267 (10.98)117 (10.01)
Hospital attributes
Hospital ownership
Public57 (9.34)937 (80.15)< 0.0001
Private553 (90.66)232 (19.85)

NT$, new Taiwan dollars; CCI, Charlson Comorbidity Index.

Of the patients with a kidney transplantation who developed severe sepsis, about 8.24% were in the low-volume (OR: 1.65; 95% CI: 1.12-2.42; P = 0.0115) physician group versus about 5.17% in the high-volume physician group (Table 3). Moreover, about 9.84% were in the low-volume hospital group (OR: 2.39; 95% CI: 1.62-3.52; P = 0.0001) versus about 4.36% in the high-volume hospital group. These findings remained significant even when we estimated the risk of developing severe sepsis within one year. The likelihood of death or graft failure within one year in the physician low-volume group was 3.1 times higher than in the high-volume group (95% CI: 1.80-5.33; P < 0.0001) and 3.17 times higher in the hospital low-volume (95% CI: 1.85-5.46; P < 0.0001) (Table 4).
Table 3

One-year severe-sepsis rate with odds ratio across physician and hospital caseload-volume groups.

Risk FactorNoneSevereSepsisOdds Ratio(95% CI)P-value
Severe sepsis in hospital
Physician volume
Low568 (91.76)51 (8.24)1.65 (1.12-2.42)0.0115
High1100 (94.83)60 (5.17)1.00
Hospital volume
Low550 (90.16)60 (9.84)2.39 (1.62-3.52)< 0.0001
High1118 (95.64)51 (4.36)1.00
Severe sepsis within one year
Physician volume
Low542 (87.56)77 (12.44)1.61 (1.17-2.22)0.0033
High1066 (91.90)94 (8.10)1.00
Hospital volume
Low525 (86.07)85 (13.93)2.04 (1.48-2.80)< 0.0001
High1083 (92.64)86 (7.36)1.00

CI, confidence interval.

Table 4

One-year graft-failure (including death) rate with odds ratios across physician and hospital caseload-volume groups

NoneDeathOdds RatioP-value
Death or graft failure within one year
Physician Volume
Low584 (94.35)35 (5.65)3.10 (1.80-5.33)< 0.0001
High1138 (98.10)22 (1.90)1.00
Hospital Volume
Low575 (94.26)35 (5.74)3.17 (1.85-5.46)< 0.0001
High1147 (98.12)22 (1.88)1.00
We also analyzed 10-year patient survival using a log-rank test to compare the likelihood of graft failure (including death) based on physician-volume and hospital-volume (Figures 1, 2). The low-volume groups had a significantly (P < 0.001) higher risk in both instances.
Figure 1

The survival curves of patients with kidneys transplanted by low-volume and high-volume physicians.

Figure 2

The survival curves of patients with kidneys transplanted in low-volume and high-volume hospitals.

To account for the possibility that patients within the same hospital-volume group may be more similar to each other than to patients in other hospital-volume groups because of specific physician and hospital treatment practices, we used a logistic regression model with the GEE method to explore the association of the 1-year severe sepsis risk with the same risk factors used for the other analyses. Patients treated by low-volume physicians still had 1.35 times the risk of developing severe sepsis than did patients treated by high-volume physicians. Physician gender was not a significant factor, but physician age was: patients treated by physicians ≤ 40 had a significantly lower risk (AOR: 0.633; P < 0.0001), but those treated by physicians > 50 had a significantly higher risk (AOR: 1.4; P < 0.0022). Female patients were significantly less likely to develop severe sepsis (AOR: 0.768; 95% CI: 0.619-0.953; P < 0.0001), but patients > 55 years old were significantly (P < 0.0001) more likely to develop it, as were patients with a higher CCI score (Table 5). Finally, patients treated in a private hospital were significantly (P < 0.0001) more likely to develop severe sepsis than were patients treated in a public hospital.
Table 5

Risk factors for one-year severe sepsis of kidney transplantation patients.

Risk FactorAdjusted Odds Ratio (95% CI)P-value
Physician attributes
Physician volume1.349 (1.254-1.452)< 0.0001
Low
High
Gender
Male
Female1.358 (0.449-4.109)0.5881
Age (years)
≤ 400.633 (0.616-0.651)< 0.0001
40-49Reference
≥ 501.400 (1.129-1.737)0.0022
Patient attributes
Gender
Male
Female0.768 (0.619-0.953)0.0165
Age (years)
≤ 201.241 (0.713-2.160)0.4442
21-55Reference
> 551.411 (1.335-1.492)< 0.0001
CCI Score
0
11.314 (1.216-1.421)< 0.0001
> 21.583 (1.392-1.800)< 0.0001
Hospital attributes
Hospital ownership
Public
Private2.537 (2.402-2.679)< 0.0001

CCI, Charlson Comorbidity Index.

Discussion

In this study, we explored the relationship between physician and hospital volumes of kidney transplantations with postoperative severe sepsis and graft failure (including death). Several studies have reported serious postoperative complications because of sepsis, which is associated with a higher risk of mortality. We found that patient who had their transplantation surgery done either by high-volume physicians or in high-volume hospitals, had a lower risk of developing severe sepsis in the hospital, even within one year. Moreover, the risk of graft failure (including death) was significantly lower in the short term (within one year) and in the long term (~10 years) after a kidney transplantation in a high-volume hospital. Since the first published article in English on the volume-outcome relationship 23, there have been numerous studies that provide similar results for research on, e.g., cardiovascular or orthopedic procedures and cancer surgery. High-volume hospitals not only have better survival rates, but they also have a lower infectious complication and reduced resource utilization 24, 25. Scare studies in the kidney transplantation applied in the above two hypothesis (practice-makes-perfect or selective-referral), not only because the rare cases in kidney transplantation, but also the serious outcomes applied in a short time which produce the unstable predication. The likelihood of graft failure (including death) within a year of the transplantation is significantly associated with each patient's personal characteristics, such as gender and age, and with relevant postoperative medical conditions, such as sepsis, which is consistent with other studies 26, 27. We found that physician-volume was, indeed, related to the risk of severe sepsis, especially for the low-volume group, and recommend that health authorities consider certifying some institutions for economic reasons or to provide the transparent information about patient's choices of hospital for quality-procedures-and-outcomes reasons. Patient characteristics, operative time, and the identity of the surgeon are perhaps the three most important factors the affect surgery outcomes 28. Although one study found a significant volume-outcome relationship at the physician level but not at the hospital level 29, there remain many unexplained factors to analyze before the relationship can be confirmed. One study 30 claims that a physician's skill or experience is important for determining clinical outcomes; however, other studies 31, 32 conclude that the volume of procedures is not the sole determiner of better outcomes and are concerned that physician overload may also affect the quality. If volume significantly affects outcomes, national departments of health may want to encourage the centralization of procedures in a few facilities. In addition, hospitals may have the benefit of producing better outcomes when treating only one or a few conditions 33. Otherwise, healthcare officials may consider requiring surgeons to take additional training and education in the low-volume procedures that they perform, or enforcing the referral system for low-volume hospitals and implement some useful quality-improvement strategies for patients. Based on all these findings, we may be able to infer some key economic implications for the feasibility and likelihood of volume-related policy options in some disease areas 34. In addition, patients with chronic kidney disease (CKD) benefits from National Health Insurance (NHI) can apply for a catastrophic illness certificate, which grants exemption from all copayments to reduce most financial barriers for treatment under the universal healthcare system in Taiwan. For patients with CKD in Taiwan, the barriers of accessibility or finance were considerably lower than in other countries to encourage them to undergo treatment. However, even though we may find a positive relationship between outcomes and volume, it is difficult to reach consensus on a cut-point for “low volume”. Health authorities may want to consider improving the efficiency of their national referral systems to increase the quality of care and reduce mortality in their countries' hospitals 35. This study has several limitations. First, the shortage of evidence supporting the hypothesis is that the volume-outcome association involves a causal relationship. For transplantation, an inverse volume-outcome relationship appears to exist 20, 36, but studies still need to consider several influences, such as patient and donor selection, case mix, timeliness of donor availability, operative technique, and so on. Moreover, one study 37 found comparable 90-day, 1-year, and 3-year survival outcomes between patients with end-stage renal disease (n = 14) and hepatocellular carcinoma (n = 14) who had undergone liver transplantation at a low-volume hospital. In addition, the NHI claim databases did not provide information related to kidney disease (for example, National Quality Forum measurement). Therefore, we are always to be cautious in the volume-outcome relationship.

Conclusions

Numerous studies have reported a positive association between high-volume physicians and better outcomes, but the debate for the threshold of a composite patient safety score for U.S. hospitals, which the Leapfrog Group has established 38, has still not ended; or perhaps the existing findings encourage patients to prefer facilities with better-than-expected outcomes and away from those with worse-than-expected outcomes. Moreover, despite studies 39 that have confirmed the volume-outcome relationship, more appropriate statistical tools are suggested to clarify some unsatisfactory situations. The findings also imply that training and staffing levels are important factors. Therefore, defining and exporting best practices through education outreach, and, if necessary, government regulation must be part of the national health policy agenda.
  38 in total

1.  The course and outcome of renal transplant recipients admitted to a general intensive care unit.

Authors:  D Kirilov; J Cohen; M Shapiro; E Grozovski; P Singer
Journal:  Transplant Proc       Date:  2003-03       Impact factor: 1.066

2.  Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS.

Authors:  Vikas R Dharnidharka; Donald M Stablein; William E Harmon
Journal:  Am J Transplant       Date:  2004-03       Impact factor: 8.086

3.  Procedure volume as a predictor of surgical outcomes.

Authors:  Edward H Livingston; Jing Cao
Journal:  JAMA       Date:  2010-07-07       Impact factor: 56.272

4.  Temporal trends in the epidemiology of severe postoperative sepsis after elective surgery: a large, nationwide sample.

Authors:  Brian T Bateman; Ulrich Schmidt; Mitchell F Berman; Edward A Bittner
Journal:  Anesthesiology       Date:  2010-04       Impact factor: 7.892

5.  High-surgical-volume hospitals associated with better quality and lower cost of kidney transplantation in Taiwan.

Authors:  Shu-Yun Tsao; Wui-Chiang Lee; Che-Chuan Loong; Tzeng-Ji Chen; Jen-Hwey Chiu; Ling-Chen Tai
Journal:  J Chin Med Assoc       Date:  2011-01-19       Impact factor: 2.743

6.  Key factors associated with postoperative complications in patients undergoing colorectal surgery.

Authors:  E Manilich; J D Vogel; R P Kiran; J M Church; Dilara Seyidova-Khoshknabi; F H Remzi
Journal:  Dis Colon Rectum       Date:  2013-01       Impact factor: 4.585

7.  Factors associated with primary and secondary graft failure following cadaveric kidney transplant.

Authors:  Inbal Weiss-Salz; Micha Mandel; Noya Galai; Irit Nave; Geoffrey Boner; Eytan Mor; Richard Nakache; Elisheva Simchen
Journal:  Clin Transplant       Date:  2004-10       Impact factor: 2.863

8.  Association between surgeon and hospital volume and in-hospital fatalities after lung cancer resections: the experience of an Asian country.

Authors:  Yung-Chang Lien; Ming-Te Huang; Herng-Ching Lin
Journal:  Ann Thorac Surg       Date:  2007-05       Impact factor: 4.330

9.  Liver transplantation at a small-volume procedure center--preliminary results from Taipei Veterans General Hospital.

Authors:  Niang-Cheng Lin; Cheng-Yuan Hsia; Che-Chuan Loong; Chin-Su Liu; Hsin-Lin Tsai; Wing-Yiu Lui; Chew-Wun Wu
Journal:  J Chin Med Assoc       Date:  2008-04       Impact factor: 2.743

10.  Relation between volume and outcome for patients with severe sepsis in United Kingdom: retrospective cohort study.

Authors:  Jason Shahin; David A Harrison; Kathryn M Rowan
Journal:  BMJ       Date:  2012-05-29
View more
  6 in total

1.  The impact of surgeon volume on patient outcome in spine surgery: a systematic review.

Authors:  Azeem Tariq Malik; Usman Younis Panni; Muhammad Usman Mirza; Maryam Tetlay; Shahryar Noordin
Journal:  Eur Spine J       Date:  2018-01-17       Impact factor: 3.134

2.  The Impact of Hospital/Surgeon Volume on Acute Renal Failure and Mortality in Liver Transplantation: A Nationwide Cohort Study.

Authors:  Chih-Wen Cheng; Fu-Chao Liu; Jr-Rung Lin; Yung-Fong Tsai; Hsiu-Pin Chen; Huang-Ping Yu
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

3.  Perioperative Complications During Living Donor Nephrectomy: Results From a Multicenter Cohort Study.

Authors:  Carlos Garcia-Ochoa; Liane S Feldman; Christopher Nguan; Mauricio Monroy-Cuadros; Jennifer Arnold; Neil Boudville; Meaghan Cuerden; Christine Dipchand; Michael Eng; John Gill; William Gourlay; Martin Karpinski; Scott Klarenbach; Greg Knoll; Krista L Lentine; Charmaine E Lok; Patrick Luke; G V Ramesh Prasad; Alp Sener; Jessica M Sontrop; Leroy Storsley; Darin Treleaven; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2019-07-18

4.  The Effect of Transplant Volume and Patient Case Mix on Center Variation in Kidney Transplantation Outcomes.

Authors:  Anne Tsampalieros; Dean Fergusson; Stephanie Dixon; Shane W English; Douglas Manuel; Carl Van Walraven; Monica Taljaard; Greg A Knoll
Journal:  Can J Kidney Health Dis       Date:  2019-09-20

5.  Center Variation and the Effect of Center and Provider Characteristics on Clinical Outcomes in Kidney Transplantation: A Systematic Review of the Evidence.

Authors:  Anne Tsampalieros; Gregory A Knoll; Nicholas Fergusson; Alexandria Bennett; Monica Taljaard; Dean Fergusson
Journal:  Can J Kidney Health Dis       Date:  2017-10-19

6.  Case Mix, Patterns of Care, and Inpatient Outcomes Among Ontario Kidney Transplant Centers: A Population-Based Study.

Authors:  Anne Tsampalieros; Greg A Knoll; Stephanie Dixon; Shane English; Douglas Manuel; Carl Van Walraven; Monica Taljaard; Dean Fergusson
Journal:  Can J Kidney Health Dis       Date:  2018-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.